clinical trial · NCT07081243
Symplicity China Study
Medtronic Vascular·—·recruiting·n = 500
Resistant HypertensionSymplicity Spyral Renal Denervation System
brief summary
The Symplicity China study will evaluate the real-world long-term safety, efficacy, and durability of the Symplicity Spyral system in a population of approximately 500 renal denervation treated subjects with up to 36 months of follow up.
started
Nov 11, 2025
primary completion
Jun 30, 2028
completion
Dec 30, 2031
last updated
Nov 17, 2025
official title
A Prospective, Single-group, Non-interventional, Non-blinded, Observational Study to Evaluate the Long-term Safety, Efficacy, and Durability of Symplicity Spyral Renal Denervation System in China
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol